Royal Bank of Canada’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Buy |
450
+66
| +17% | – | ﹤0.01% | 6809 |
|
|
2025
Q1 | $0 | Sell |
384
-40,000
| -99% | – | ﹤0.01% | 6618 |
|
|
2024
Q4 | $61K | Buy |
40,384
+40,336
| +84,033% | +$60.9K | ﹤0.01% | 5115 |
|
|
2024
Q3 | $0 | Sell |
48
-2,358
| -98% | – | ﹤0.01% | 6772 |
|
|
2024
Q2 | $4K | Buy |
2,406
+1,458
| +154% | +$2.42K | ﹤0.01% | 6214 |
|
|
2024
Q1 | $2K | Sell |
948
-11,017
| -92% | -$23.2K | ﹤0.01% | 6240 |
|
|
2023
Q4 | $38K | Buy |
11,965
+5,479
| +84% | +$17.4K | ﹤0.01% | 5569 |
|
|
2023
Q3 | $40K | Buy |
6,486
+2,462
| +61% | +$15.2K | ﹤0.01% | 5409 |
|
|
2023
Q2 | $25K | Buy |
4,024
+1,957
| +95% | +$12.2K | ﹤0.01% | 5641 |
|
|
2023
Q1 | $10K | Sell |
2,067
-2,770
| -57% | -$13.4K | ﹤0.01% | 5934 |
|
|
2022
Q4 | $42K | Buy |
4,837
+4,388
| +977% | +$38.1K | ﹤0.01% | 5518 |
|
|
2022
Q3 | $5K | Buy |
449
+242
| +117% | +$2.7K | ﹤0.01% | 6249 |
|
|
2022
Q2 | $3K | Sell |
207
-1,404
| -87% | -$20.3K | ﹤0.01% | 6380 |
|
|
2022
Q1 | $34K | Sell |
1,611
-4,395
| -73% | -$92.8K | ﹤0.01% | 5837 |
|
|
2021
Q4 | $139K | Buy |
6,006
+3,725
| +163% | +$86.2K | ﹤0.01% | 5158 |
|
|
2021
Q3 | $68K | Buy |
2,281
+453
| +25% | +$13.5K | ﹤0.01% | 5461 |
|
|
2021
Q2 | $62K | Buy |
1,828
+735
| +67% | +$24.9K | ﹤0.01% | 5406 |
|
|
2021
Q1 | $36K | Buy |
1,093
+678
| +163% | +$22.3K | ﹤0.01% | 5595 |
|
|
2020
Q4 | $26K | Buy |
+415
| New | +$26K | ﹤0.01% | 5389 |
|